Positions 26–50 of 62.
Reporting in. anyone else notice T2D kicking in around week 89. On hypoglycaemia, because the risk gets attributed to the wrong thing constantly. Incretin-based agents…
Slightly embarrassed to be asking this, but: someone explain glycaemic control to me like I have not read a paper in years. Time in range told me far more than the…
can we stop arguing about T2D until somebody posts a number. I am not trying to be the "source?" guy. I would just like a source. Postprandial excursions typically…
Genuine question, and the title is the question: why does nobody talk about A1c. My TSH moved and it turned out to have nothing to do with glucose at all. Variability…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsSlightly embarrassed to be asking this, but: how do you actually verify glycaemic control. My A1c moved and it turned out to have nothing to do with glucose at all. The…
the CGM question that gets asked weekly, answered properly. Not a hot take, just something I have not seen said plainly here. Kept fingersticks alongside the sensor for…
the A1c question that gets asked weekly, answered properly. Not a hot take, just something I have not seen said plainly here. Continuous monitoring shows the shape:…
Something I keep coming back to: the hypoglycaemia question that gets asked weekly, answered properly. My A1c moved and it turned out to have nothing to do with glucose…
Six-word version is the title — 38 weeks, 14kg, and T2D was the hard part — and the rest is context. 38 weeks and 14kg. Those are measured, not estimated, and not…
the T2D rule is doing its job and people should stop complaining. Nothing about this affects the ranking maths, before anyone asks. Assumed the weight endpoints from…
small win: glycaemic control stopped being a problem at week 17, logged the same way every week so the comparison is at least internally fair. Panicked over a first-day…
13 months in and CGM is still the thing I get wrong, and the part I actually want to talk about is at the bottom. Pulling the figures out of the title: 13 months. All…
the weight conversation drowns out the glycaemic one — a position I have arrived at slowly and would like tested. The order things move in, since nobody explains it and…
A1c: the version I wish someone had shown me in week 1. Numbers below. Ask me the boring questions, they are the useful ones. A1c reflects average glycaemia over…
unpopular opinion: most of what gets said here about hypoglycaemia is guesswork. Not a hot take, just something I have not seen said plainly here. Postprandial…
Send the vial, get the number. Third-party purity and identity testing, results published to you regardless of what they say.
Test a vialSponsoredEst. 1998. ISO 9001 and cGMP, 1,500+ staff, 200+ patents. There is a fair chance the vial you are about to send for testing started here. Batch-specific COA as standard.
glbiochem.netstacking with a sulfonylurea is a real hypo risk, not a theoretical one, which sounds obvious until you try to state the evidence for it. Certain conditions affect A1c…
A1c 5.6 but CGM says otherwise. which do i believe. I would rather ask a basic question now than get this wrong quietly for two months. Postprandial excursions…
CGM — what am I missing here. I would rather ask a basic question now than get this wrong quietly for two months. Kept fingersticks alongside the sensor for two weeks…
Check-in as promised in the title: anyone else notice hypoglycaemia kicking in around week 8. On hypoglycaemia, because the risk gets attributed to the wrong thing…
how do you actually verify A1c — that is what I am asking, and I have already read the wiki twice. Assumed the weight endpoints from the obesity trials applied to my…
5 months in and metformin is still the thing I get wrong. This is a description of what happened to me and not a plan for anybody else. Numbers, in the order they…
Asking properly rather than in a comment on somebody else’s thread: what would you tell week-1 you about glycaemic control. Brought the whole CGM export to my…
the hypoglycaemia rule is doing its job and people should stop complaining. Nothing about this affects the ranking maths, before anyone asks. The diabetes and obesity…
metformin alongside — keep it or drop it. I am not trying to be the "source?" guy. I would just like a source. Panicked over a first-day sensor reading and rebuilt my…
Thinking out loud about this: we are measuring T2D at the wrong time and calling it noise. Assumed the weight endpoints from the obesity trials applied to my situation.…
Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference